Pain Intensity and Trajectory Following Intra-Articular Injection of Mono-Iodoacetate in Experimental Osteoarthritis: A Meta-Analysis of In Vivo Studies
Open Access
- 10 January 2023
- journal article
- research article
- Published by SAGE Publications in CARTILAGE
- Vol. 14 (1) , 86-93
Abstract
Objective: Although most frequently used in experimental osteoarthritis (OA) pain induction, intra-articular mono-iodoacetate (MIA) injection lacks concluded references for dose selection and timing of intervention. Herein, we aimed to compare the pain intensity of rats induced by different doses of MIA and explored the trajectory of pain. Design: PubMed, Embase, and Web of Science were searched up to June 2021 for literatures involving MIA experiments investigating OA pain. Pain intensity was measured based on weightbearing distribution (WBD) and paw withdrawal thresholds (PWT), and the pain trajectory was constructed by evaluating pain intensity at a series of time points after MIA injection. A conventional meta-analysis was conducted. Results: A total of 140 studies were included. Compared with saline, MIA injections caused significantly higher pain intensity for WBD and PWT. Dose-response relationships between different doses of MIA and pain intensity were observed ( P-for-trend<0.05). A pronounced increase in pain occurred from day 0 to day 7, but the uptrend ceased between day 7 and day 14, after which the pain intensity continued to rise and reached the maximum by day 28. Conclusions: Pain intensity after intra-articular MIA injection increased in a dose-dependent manner and the pain trajectory manifested a specific pattern consistent with the pathological mechanisms of MIA-induced pain, providing possible clues for proper dose selection and timing of specific OA pain interventions.Keywords
Funding Information
- National Natural Science Foundation of China (81902264)
- National Natural Science Foundation of China (81902265)
This publication has 45 references indexed in Scilit:
- Local ASIC3 modulates pain and disease progression in a rat model of osteoarthritisJournal of Biomedical Science, 2012
- Characterisation of a Peripheral Neuropathic Component of the Rat Monoiodoacetate Model of OsteoarthritisPLOS ONE, 2012
- Gastrointestinal and Cardiovascular Risk of NonsteroidalAnti-inflammatory DrugsOman Medical Journal, 2011
- Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis painArthritis & Rheumatism, 2010
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain modelArthritis & Rheumatism, 2010
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Inhibition of fatty acid amide hydrolase and cyclooxygenase-2 increases levels of endocannabinoid related molecules and produces analgesia via peroxisome proliferator-activated receptor-alpha in a model of inflammatory painNeuropharmacology, 2008
- Pain related behaviour in two models of osteoarthritis in the rat kneePain, 2004
- Mono‐iodoacetate‐induced experimental osteoarthritis. A dose‐response study of loss of mobility, morphology, and biochemistryArthritis & Rheumatism, 1997